Portal de Periódicos da CAPES

Total Lymphoid Irradiation in Refractory Systemic Lupus Erythematosus

1986; American College of Physicians; Volume: 105; Issue: 1 Linguagem: Inglês

10.7326/0003-4819-105-1-58

1539-3704

Eldad Ben‐Chetrit, David J. Gross, Abraham Braverman, Z Weshler, Zvi Fuks, S Slavin, M Eliakim,

Systemic Sclerosis and Related Diseases

In two patients with systemic lupus erythematosus, conventional therapy was considered to have failed because of persistent disease activity and unacceptable side effects. Both were treated with total lymphoid irradiation without clinical benefit, despite adequate immunosuppression as documented by markedly reduced numbers of circulating T lymphocytes and T-lymphocytedependent proliferative responses in vitro. The first patient developed herpes zoster, gram-negative septicemia, neurologic symptoms, and deterioration of lupus nephritis. The second patient developed massive bronchopneumonia, necrotic cutaneous lesions, and progressive nephritis and died 2 weeks after completion of radiotherapy. These observations, although limited to two patients, indicate that total lymphoid irradiation in patients with severe systemic lupus erythematosus should be regarded as strictly experimental.